Cite
MLA Citation
Niklas Bergvall et al.. “Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.” Current medical research and opinion, vol. 30, n.d., pp. 1461–1471. http://access.bl.uk/ark:/81055/vdc_100024933996.0x00000b